China Biologic Therapeutics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Biologic Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biologic Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Biologic Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GlaxoSmithKline

    • AstraZeneca

    • Novartis Global

    • Pfizer

    • Merck

    • Aurobindo Pharma

    By Type:

    • Vaccines

    • Blood Products

    • Allergenic Extracts

    • Human Cells and Tissues

    • Gene Therapies

    • Protein

    • Cellular Therapies

    • Xenotransplantation Products

    By End-User:

    • Rheumatoid Arthritis

    • Anemia

    • Cancer

    • Diabetes

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologic Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Biologic Therapeutics Market Size and Growth Rate of Vaccines from 2016 to 2027

    • 1.3.2 China Biologic Therapeutics Market Size and Growth Rate of Blood Products from 2016 to 2027

    • 1.3.3 China Biologic Therapeutics Market Size and Growth Rate of Allergenic Extracts from 2016 to 2027

    • 1.3.4 China Biologic Therapeutics Market Size and Growth Rate of Human Cells and Tissues from 2016 to 2027

    • 1.3.5 China Biologic Therapeutics Market Size and Growth Rate of Gene Therapies from 2016 to 2027

    • 1.3.6 China Biologic Therapeutics Market Size and Growth Rate of Protein from 2016 to 2027

    • 1.3.7 China Biologic Therapeutics Market Size and Growth Rate of Cellular Therapies from 2016 to 2027

    • 1.3.8 China Biologic Therapeutics Market Size and Growth Rate of Xenotransplantation Products from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Biologic Therapeutics Market Size and Growth Rate of Rheumatoid Arthritis from 2016 to 2027

    • 1.4.2 China Biologic Therapeutics Market Size and Growth Rate of Anemia from 2016 to 2027

    • 1.4.3 China Biologic Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027

    • 1.4.4 China Biologic Therapeutics Market Size and Growth Rate of Diabetes from 2016 to 2027

    • 1.4.5 China Biologic Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biologic Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biologic Therapeutics by Major Types

    • 3.4.1 Market Size and Growth Rate of Vaccines

    • 3.4.2 Market Size and Growth Rate of Blood Products

    • 3.4.3 Market Size and Growth Rate of Allergenic Extracts

    • 3.4.4 Market Size and Growth Rate of Human Cells and Tissues

    • 3.4.5 Market Size and Growth Rate of Gene Therapies

    • 3.4.6 Market Size and Growth Rate of Protein

    • 3.4.7 Market Size and Growth Rate of Cellular Therapies

    • 3.4.8 Market Size and Growth Rate of Xenotransplantation Products

    4 Segmentation of Biologic Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biologic Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Biologic Therapeutics in Rheumatoid Arthritis

    • 4.4.2 Market Size and Growth Rate of Biologic Therapeutics in Anemia

    • 4.4.3 Market Size and Growth Rate of Biologic Therapeutics in Cancer

    • 4.4.4 Market Size and Growth Rate of Biologic Therapeutics in Diabetes

    • 4.4.5 Market Size and Growth Rate of Biologic Therapeutics in Others

    5 Market Analysis by Regions

    • 5.1 China Biologic Therapeutics Production Analysis by Regions

    • 5.2 China Biologic Therapeutics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Biologic Therapeutics Landscape Analysis

    • 6.1 North China Biologic Therapeutics Landscape Analysis by Major Types

    • 6.2 North China Biologic Therapeutics Landscape Analysis by Major End-Users

    7 Central China Biologic Therapeutics Landscape Analysis

    • 7.1 Central China Biologic Therapeutics Landscape Analysis by Major Types

    • 7.2 Central China Biologic Therapeutics Landscape Analysis by Major End-Users

    8 South China Biologic Therapeutics Landscape Analysis

    • 8.1 South China Biologic Therapeutics Landscape Analysis by Major Types

    • 8.2 South China Biologic Therapeutics Landscape Analysis by Major End-Users

    9 East China Biologic Therapeutics Landscape Analysis

    • 9.1 East China Biologic Therapeutics Landscape Analysis by Major Types

    • 9.2 East China Biologic Therapeutics Landscape Analysis by Major End-Users

    10 Northeast China Biologic Therapeutics Landscape Analysis

    • 10.1 Northeast China Biologic Therapeutics Landscape Analysis by Major Types

    • 10.2 Northeast China Biologic Therapeutics Landscape Analysis by Major End-Users

    11 Southwest China Biologic Therapeutics Landscape Analysis

    • 11.1 Southwest China Biologic Therapeutics Landscape Analysis by Major Types

    • 11.2 Southwest China Biologic Therapeutics Landscape Analysis by Major End-Users

    12 Northwest China Biologic Therapeutics Landscape Analysis

    • 12.1 Northwest China Biologic Therapeutics Landscape Analysis by Major Types

    • 12.2 Northwest China Biologic Therapeutics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 GlaxoSmithKline

      • 13.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 AstraZeneca

      • 13.2.1 AstraZeneca Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Novartis Global

      • 13.3.1 Novartis Global Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Pfizer

      • 13.4.1 Pfizer Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Merck

      • 13.5.1 Merck Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Aurobindo Pharma

      • 13.6.1 Aurobindo Pharma Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Vaccines from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Blood Products from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Allergenic Extracts from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Human Cells and Tissues from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Gene Therapies from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Protein from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Cellular Therapies from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Xenotransplantation Products from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Rheumatoid Arthritis from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Anemia from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Diabetes from 2016 to 2027

    • Figure China Biologic Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Biologic Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biologic Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biologic Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biologic Therapeutics by Different Types from 2016 to 2027

    • Table Consumption Share of Biologic Therapeutics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Vaccines

    • Figure Market Size and Growth Rate of Blood Products

    • Figure Market Size and Growth Rate of Allergenic Extracts

    • Figure Market Size and Growth Rate of Human Cells and Tissues

    • Figure Market Size and Growth Rate of Gene Therapies

    • Figure Market Size and Growth Rate of Protein

    • Figure Market Size and Growth Rate of Cellular Therapies

    • Figure Market Size and Growth Rate of Xenotransplantation Products

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biologic Therapeutics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biologic Therapeutics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Rheumatoid Arthritis

    • Figure Market Size and Growth Rate of Anemia

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Others

    • Table China Biologic Therapeutics Production by Regions

    • Table China Biologic Therapeutics Production Share by Regions

    • Figure China Biologic Therapeutics Production Share by Regions in 2016

    • Figure China Biologic Therapeutics Production Share by Regions in 2021

    • Figure China Biologic Therapeutics Production Share by Regions in 2027

    • Table China Biologic Therapeutics Consumption by Regions

    • Table China Biologic Therapeutics Consumption Share by Regions

    • Figure China Biologic Therapeutics Consumption Share by Regions in 2016

    • Figure China Biologic Therapeutics Consumption Share by Regions in 2021

    • Figure China Biologic Therapeutics Consumption Share by Regions in 2027

    • Table North China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table North China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure North China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure North China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure North China Biologic Therapeutics Consumption Share by Types in 2027

    • Table North China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table North China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure North China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure North China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table Central China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table Central China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Central China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure Central China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure Central China Biologic Therapeutics Consumption Share by Types in 2027

    • Table Central China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Central China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure Central China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure Central China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table South China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table South China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure South China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure South China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure South China Biologic Therapeutics Consumption Share by Types in 2027

    • Table South China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table South China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure South China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure South China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table East China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table East China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure East China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure East China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure East China Biologic Therapeutics Consumption Share by Types in 2027

    • Table East China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table East China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure East China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure East China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table Northeast China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table Northeast China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure Northeast China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure Northeast China Biologic Therapeutics Consumption Share by Types in 2027

    • Table Northeast China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure Northeast China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure Northeast China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table Southwest China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table Southwest China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure Southwest China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure Southwest China Biologic Therapeutics Consumption Share by Types in 2027

    • Table Southwest China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure Southwest China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure Southwest China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table Northwest China Biologic Therapeutics Consumption by Types from 2016 to 2027

    • Table Northwest China Biologic Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Biologic Therapeutics Consumption Share by Types in 2016

    • Figure Northwest China Biologic Therapeutics Consumption Share by Types in 2021

    • Figure Northwest China Biologic Therapeutics Consumption Share by Types in 2027

    • Table Northwest China Biologic Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Biologic Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Biologic Therapeutics Consumption Share by End-Users in 2016

    • Figure Northwest China Biologic Therapeutics Consumption Share by End-Users in 2021

    • Figure Northwest China Biologic Therapeutics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Novartis Global

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Global

    • Figure Sales and Growth Rate Analysis of Novartis Global

    • Figure Revenue and Market Share Analysis of Novartis Global

    • Table Product and Service Introduction of Novartis Global

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Aurobindo Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma

    • Figure Sales and Growth Rate Analysis of Aurobindo Pharma

    • Figure Revenue and Market Share Analysis of Aurobindo Pharma

    • Table Product and Service Introduction of Aurobindo Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.